Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32374544!ä!32374544 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Rev+Med+Suisse 2020 ; 16 (692): 951-954 Nephropedia Template TP {{tp|p=32374544|t=2020. Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives |pdf=|usr=}}{{32374544}} gab.com Text Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives JO: Rev Med Suisse http://www.kidney.de/pget.php?&tw=1&pmid=32374544 #FOAvip Since the SARS-CoV-2 pandemic outbreak, growing evidence suggests that patients suffering from COVID-19 are at increased risk of thrombotic events. The sepsis-related activation of the coagulation combined with a high prevalence of common thrombotic risk factors could contribute to this prothrombotic state. Coagulation biomarkers could help in the identification of patients at risk of complications and mortality. The incidence of venous thromboembolic events appears to be increased, especially in severe COVID-19 patients. Based on that knowledge, several societies have provided recommendation on the prevention of venous thromboembolism. In this narrative review, we summarize available epidemiologic data on venous thromboembolism and recommendations on thromboprophylaxis in COVID-19. Twit Text FOAVip Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives ????Rev Med Suisse http://www.kidney.de/pget.php?&tw=1&pmid=32374544 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32374544 #FOAvip English Wikipedia <ref>{{Cite pmid|32374544}}</ref> Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, recommandations et perspectives #MMPMID32374544 Casini A; Fontana P; Glauser F; Robert-Ebadi H; Righini M; Blondon M Rev Med Suisse 2020[May]; 16 (692): 951-954 PMID32374544show ga Since the SARS-CoV-2 pandemic outbreak, growing evidence suggests that patients suffering from COVID-19 are at increased risk of thrombotic events. The sepsis-related activation of the coagulation combined with a high prevalence of common thrombotic risk factors could contribute to this prothrombotic state. Coagulation biomarkers could help in the identification of patients at risk of complications and mortality. The incidence of venous thromboembolic events appears to be increased, especially in severe COVID-19 patients. Based on that knowledge, several societies have provided recommendation on the prevention of venous thromboembolism. In this narrative review, we summarize available epidemiologic data on venous thromboembolism and recommendations on thromboprophylaxis in COVID-19. |*Severe acute respiratory syndrome-related coronavirus[MESH] |*Venous Thromboembolism/etiology/prevention & control[MESH] |Anticoagulants[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications[MESH] |Prevalence[MESH] |Risk[MESH]Risque thrombotique veineux induit par le SARS-CoV-2 : prevalence, re(epmc).pdf DeepDyve Pubget Overpricing